Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

August 01, 2012 (Vol. 32, No. 14)

Monoclonal Antibodies Enter Golden Age

  • The diversity of development tools, an abundance of manufacturing options, and standardization of many unit operations has ushered in a golden age for monoclonal antibodies (mAbs). mAb process development and GMP manufacturing increasingly rely on platform processes involving streamlined production (usually a two to three week fed-batch cell culture), ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.